StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)

Close on Nov 18, 2026Market cap $13.03MP/E –Yield –

Niki BioSolutions cash

Cash and short-term investments held at the end of each period.

Niki BioSolutions's cash was $3.45M at Dec 31, 2025. For fiscal 2025 it was $3.45M, up 295.0% from the year before. The highest annual figure on record is $27.12M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.45M+295.0%
FY2024Dec 31, 2024$874.24K-56.4%
FY2023Dec 31, 2023$2.01M-60.8%
FY2022Dec 31, 2022$5.12M-39.8%
FY2021Dec 31, 2021$8.50M+134.4%
FY2020Dec 31, 2020$3.63M-43.0%
FY2019Dec 31, 2019$6.36M-76.6%
FY2018Dec 31, 2018$27.12M+45.0%
FY2017Dec 31, 2017$18.70M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$3.45M+357.6%
Q3 FY2025Sep 30, 2025$2.27M+190.2%
Q2 FY2025Jun 30, 2025$2.76M+37.5%
Q4 FY2024Dec 31, 2024$874.24K+156.9%
Q3 FY2024Sep 30, 2024$754.59K-85.2%
Q2 FY2024Jun 30, 2024$783.09K-80.7%
Q4 FY2023Dec 31, 2023$2.01M-76.4%
Q2 FY2023Jun 30, 2023$340.31K-98.3%
Q4 FY2022Dec 31, 2022$5.12M+41.1%
Q2 FY2022Jun 30, 2022$4.07M-8.1%
Q4 FY2021Dec 31, 2021$8.50M+33.7%
Q2 FY2021Jun 30, 2021$20.07M+349.2%
Q4 FY2020Dec 31, 2020$3.63M-86.6%
Q2 FY2020Jun 30, 2020$4.43M-76.3%
Q4 FY2019Dec 31, 2019$6.36M–
Q2 FY2019Jun 30, 2019$4.47M–
Q4 FY2018Dec 31, 2018$27.12M–
Q4 FY2017Dec 31, 2017$18.70M–

More Niki BioSolutions figures

See a number that looks wrong?